AAPS PharmSciTech

, 20:150 | Cite as

Improved Oral Absorption of Poorly Soluble Curcumin via the Concomitant Use of Borneol

  • Ying Gao
  • Guo Chen
  • Xiaojiao Luan
  • Meijuan Zou
  • Hongyu Piao
  • Gang ChengEmail author
Research Article


In this study, borneol, a natural active compound was applied to improve the bioavailability of curcumin (CUR). In order to increase CUR solubility and dissolution, solid dispersions (SDs) were prepared with the matrix of polyvinylpyrrolidone (PVP) at various ratios by solvent evaporation method. CUR was evidenced to exist as amorphous state in solid dispersion by differential scanning calorimetry (DSC) and powder X-ray diffraction (PXRD). Fourier-transform infrared spectroscopy (FT-IR) was utilized to confirm intermolecular hydrogen bonding. The SD at the ratio of 1:3 (CUR:PVP) exhibited the optimal solubility and dissolution rate in various media. The results of ex vivo permeability studies by everted gut sac method showed that the apparent permeability coefficients (Papp) of CUR in SD across the duodenum, jejunum, and ileum had been significantly improved by co-incubation of borneol, and the improvement degree relied on the concentration of borneol. The pharmacokinetic results in rats indicated that the AUC0-t of CUR-SD (40 mg/kg) co-administration of borneol (90 mg/kg) were 2.53-fold higher than CUR-SD alone, and 19.41-fold higher than pure CUR (200 mg/kg) with borneol (90 mg/kg). Therefore, the combination of borneol and solid dispersion strategy provide a potential approach to enhance the oral bioavailability of CUR.

Key Words

curcumin borneol absorption everted gut sac method pharmacokinetics 


Funding Information

This work was supported by the disruptive technologies innovation fund of Shenyang Pharmaceutical University (DFJJ2018208) and the Natural Science Foundation of Liaoning Province of China (Grant No. 201602706).

Compliance with Ethical Standards

All animal experiments were carried out in accordance with the Guidelines for the Use of Laboratory Animals and approved by the Shenyang Pharmaceutical University Ethics Committee.


  1. 1.
    Bhattacharyya S, Mandal D, Sen GS, Pal S, Banerjee S, Lahiry L, et al. Tumor-induced oxidative stress perturbs nuclear factor-κB activity-augmenting tumor necrosis factor-α–mediated T-cell death: protection by curcumin. Cancer Res. 2007;67(1):362–70. Scholar
  2. 2.
    Joe B, Lokesh BR. Role of capsaicin, curcumin and dietary n-3 fatty acids in lowering the generation of reactive oxygen species in rat peritoneal macrophages. Biochim Biophys Acta. 1994;1224(2):255–63.CrossRefGoogle Scholar
  3. 3.
    Joe B, Vijaykumar M, Lokesh BR. Biological properties of curcumin-cellular and molecular mechanisms of action. Crit Rev Food Sci Nutr. 2004;44(2):97–111. Scholar
  4. 4.
    Basnet P, Skalko-Basnet N. Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules. 2011;16(6):4567–98. Scholar
  5. 5.
    Begum AN, Jones MR, Lim GP, Morihara T, Kim P, Heath DD, et al. Curcumin structure-function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer’s disease. J Pharmacol Exp Ther. 2008;326(1):196–208. Scholar
  6. 6.
    DiSilvestro RA, Joseph E, Zhao S, Bomser J. Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people. Nutr J. 2012;11:79. Scholar
  7. 7.
    Wahlang B, Pawar YB, Bansal AK. Identification of permeability-related hurdles in oral delivery of curcumin using the Caco-2 cell model. Eur J Pharm Biopharm. 2011;77(2):275–82. Scholar
  8. 8.
    Liu W, Zhai Y, Heng X, Che FY, Chen W, Sun D, et al. Oral bioavailability of curcumin: problems and advancements. J Drug Target. 2016;24(8):694–702. Scholar
  9. 9.
    Yang KY, Lin LC, Tseng TY, Wang SC, Tsai TH. Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS. J Chromatogr B Anal Technol Biomed Life Sci. 2007;853(1–2):183–9. Scholar
  10. 10.
    Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007;4(6):807–18. Scholar
  11. 11.
    Maiti K, Mukherjee K, Gantait A, Saha BP, Mukherjee PK. Curcumin-phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats. Int J Pharm. 2007;330(1–2):155–63. Scholar
  12. 12.
    Jang DJ, Kim ST, Oh E, Lee K. Enhanced oral bioavailability and antiasthmatic efficacy of curcumin using redispersible dry emulsion. Biomed Mater Eng. 2014;24(1):917–30. Scholar
  13. 13.
    Schiborr C, Kocher A, Behnam D, Jandasek J, Toelstede S, Frank J. The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes. Mol Nutr Food Res. 2014;58(3):516–27. Scholar
  14. 14.
    Jang SW, Kang MJ. Improved oral absorption and chemical stability of everolimus via preparation of solid dispersion using solvent wetting technique. Int J Pharm. 2014;473(1–2):187–93. Scholar
  15. 15.
    Chen J, Li L, Su J, Chen T. Natural borneol enhances bisdemethoxycurcumin-induced cell cycle arrest in the G2/M phase through up-regulation of intracellular ROS in HepG2 cells. Food Funct. 2015;6(3):740–8. Scholar
  16. 16.
    Cui Y, Li L, Zhang L, Li J, Gu J, Gong H, et al. Enhancement and mechanism of transdermal absorption of terpene-induced propranolol hydrochloride. Arch Pharm Res. 2011;34(9):1477–85. Scholar
  17. 17.
    Liu J, Fu S, Wei N, Hou Y, Zhang X, Cui H. The effects of combined menthol and borneol on fluconazole permeation through the cornea ex vivo. Eur J Pharmacol. 2012;688(1–3):1–5. Scholar
  18. 18.
    Lu Y, Chen X, Du S, Wu Q, Yao Z, Zhai Y. The in situ and in vivo study on enhancing effect of borneol in nasal absorption of Geniposide in rats. Arch Pharm Res. 2010;33(5):691–6. Scholar
  19. 19.
    Yi T, Tang D, Wang F, Zhang J, Zhang J, Wang J, et al. Enhancing both oral bioavailability and brain penetration of puerarin using borneol in combination with preparation technologies. Drug Deliv. 2017;24(1):422–9. Scholar
  20. 20.
    Zhou Y, Li W, Chen L, Ma S, Ping L, Yang Z. Enhancement of intestinal absorption of akebia saponin D by borneol and probenecid in situ and in vitro. Environ Toxicol Pharmacol. 2010;29(3):229–34. Scholar
  21. 21.
    Tang B, Fang GH, Gao Y, Liu Y, Liu JW, Zou MJ, et al. Co-encapsulation of borneol and paclitaxel by liprosomes improved anti-tumor effect in a xenografted glioma model. RSC Adv. 2015;5(129):106613–20. Scholar
  22. 22.
    Chen J, Li L, Su J, Li B, Chen T, Wong YS. Synergistic apoptosis-inducing effects on A375 human melanoma cells of natural borneol and curcumin. PLoS One. 2014;9(6):e101277. Scholar
  23. 23.
    Sadeghi F, Ashofteh M, Homayouni A, Abbaspour M, Nokhodchi A, Garekani HA. Antisolvent precipitation technique: a very promising approach to crystallize curcumin in presence of polyvinyl pyrrolidon for solubility and dissolution enhancement. Colloids Surf B Biointerfaces. 2016;147:258–64. Scholar
  24. 24.
    Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13(2):123–33.CrossRefGoogle Scholar
  25. 25.
    Wang Y, Zou M, Zhao N, Ren J, Zhou H, Cheng G. Effect of diallyl trisulfide on the pharmacokinetics of dipyridamole in rats. Arch Pharm Res. 2011;34(11):1957–64. Scholar
  26. 26.
    Frizon F, Eloy JD, Donaduzzi CM, Mitsui ML, Marchetti JM. Dissolution rate enhancement of loratadine in polyvinylpyrrolidone K-30 solid dispersions by solvent methods. Powder Technol. 2013;235:532–9. Scholar
  27. 27.
    Tantishaiyakul V, Kaewnopparat N, Ingkatawornwong S. Properties of solid dispersions of piroxicam in polyvinylpyrrolidone. Int J Pharm. 1999;181(2):143–51.CrossRefGoogle Scholar
  28. 28.
    Paradkar A, Ambike AA, Jadhav BK, Mahadik KR. Characterization of curcumin–PVP solid dispersion obtained by spray drying. Int J Pharm. 2004;271(1–2):281–6. Scholar
  29. 29.
    Zhang Q, Polyakov NE, Chistyachenko YS, Khvostov MV, Frolova TS, Tolstikova TG, et al. Preparation of curcumin self-micelle solid dispersion with enhanced bioavailability and cytotoxic activity by mechanochemistry. Drug Deliv. 2018;25(1):198–209. Scholar
  30. 30.
    Barzegar-Jalali M, Alaei-Beirami M, Javadzadeh Y, Mohammadi G, Hamidi A, Andalib S, et al. Comparison of physicochemical characteristics and drug release of diclofenac sodium-eudragit (R) RS100 nanoparticles and solid dispersions. Powder Technol. 2012;219:211–6. Scholar
  31. 31.
    Wang C, Ma C, Wu Z, Liang H, Yan P, Song J, et al. Enhanced bioavailability and anticancer effect of curcumin-loaded electrospun nanofiber: in vitro and in vivo study. Nanoscale Res Lett. 2015;10(1):439. Scholar
  32. 32.
    Sethia S, Squillante E. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. Int J Pharm. 2004;272(1–2):1–10. Scholar
  33. 33.
    Chen S, Zhu J, Ma F, Fang Q, Li Y. Preparation and characterization of solid dispersions of dipyridarmole with a carrier “copolywidonum plasdone (R) S-630”. Drug Dev Ind Pharm. 2007;33(8):888–99. Scholar
  34. 34.
    Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm. 2000;50(1):47–60.CrossRefGoogle Scholar
  35. 35.
    Tran TT, Tran KA, Tran PH. Modulation of particle size and molecular interactions by sonoprecipitation method for enhancing dissolution rate of poorly water-soluble drug. Ultrason Sonochem. 2015;24:256–63. Scholar
  36. 36.
    Khemiss F, Massoudi R, Ahmadi S, Ghoul-Mazgar S, Safta S, Moshtaghie AA, et al. Aeromonas hydrophila disturbs water and electrolyte transport in Mugil cephalus L. intestine. Afr J Biotechnol. 2008;7(4):373–80.Google Scholar
  37. 37.
    Gao Y, He L, Katsumi H, Sakane T, Fujita T, Yamamoto A. Improvement of intestinal absorption of water-soluble macromolecules by various polyamines: intestinal mucosal toxicity and absorption-enhancing mechanism of spermine. Int J Pharm. 2008;354(1–2):126–34. Scholar
  38. 38.
    Duan M, Xing Y, Guo J, Chen H, Zhang R. Borneol increases blood-tumour barrier permeability by regulating the expression levels of tight junction-associated proteins. Pharm Biol. 2016;54(12):3009–18. Scholar
  39. 39.
    Wang S, Tan N, Ma C, Wang J, Jia P, Liu J, et al. Inhibitory effects of benzaldehyde, vanillin, muscone and borneol on P-glycoprotein in Caco-2 cells and everted gut sac. Pharmacology. 2018;101(5–6):269–77. Scholar
  40. 40.
    Yu B, Ruan M, Dong X, Yu Y, Cheng H. The mechanism of the opening of the blood-brain barrier by borneol: a pharmacodynamics and pharmacokinetics combination study. J Ethnopharmacol. 2013;150:1096–108. Scholar
  41. 41.
    He H, Shen Q, Li J. Effects of borneol on the intestinal transport and absorption of two P-glycoprotein substrates in rats. Arch Pharm Res. 2011;34(7):1161–70. Scholar
  42. 42.
    Wang R, Wu Z, Yang S, Guo S, Dai X, Qiao Y, et al. A molecular interpretation on the different penetration enhancement effect of borneol and menthol towards 5-fluorouracil. Int J Mol Sci. 2017;18(12). Scholar

Copyright information

© American Association of Pharmaceutical Scientists 2019

Authors and Affiliations

  • Ying Gao
    • 1
  • Guo Chen
    • 1
  • Xiaojiao Luan
    • 1
  • Meijuan Zou
    • 1
  • Hongyu Piao
    • 1
  • Gang Cheng
    • 1
    Email author
  1. 1.Department of Pharmaceutics, School of PharmacyShenyang Pharmaceutical UniversityShenyangChina

Personalised recommendations